Use of 17-ketosteroid compounds and derivatives, metabolites and precursors thereof in the treatment of malaria and the treatment of African and American trypanosomiasis

Details for Australian Patent Application No. 2004237812 (hide)

Owner Hollis-Eden Pharmaceuticals, Inc.

Inventors Prendergast, PatrickT; Frincke, James Martin; Ahlem, Clarence Nathaniel

Agent Griffith Hack

Pub. Number AU-A-2004237812

Parent 776853

Filing date 8 December 2004

Wipo publication date 13 January 2005

Acceptance publication date 29 November 2007

International Classifications

A61K 031/56 - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61P 033/02 Antiparasitic agents

A61P 033/06 Antiparasitic agents

Event Publications

23 December 2004 Complete Application Filed

13 January 2005 Application Open to Public Inspection

  Published as AU-A-2004237812

29 November 2007 Application Accepted

  Published as AU-A-2004237812

3 April 2008 Standard Patent Sealed

18 June 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004237813-Rapidly disintegrating methylcellulose tablets

2004237811-Quad-directional-lead flat-package ICmounting printed circuit board, method of soldering quad-directional-lead flatpackage IC, and air conditioning apparatus with quad-directional-lead flatpackage IC-mounting printed circuit board